Radiofrequency ablation (RFA) is a medical procedure, which uses thermal energy to accomplish targeted tissue destruction.

RFA technology is used to treat a wide range of medical conditions. It is used in the treatment of tumour spot, to treat patients suffering from the adrenal gland, breast, bone, kidney, liver, lung, pancreatic, and thyroid cancer.

Radiofrequency Ablation Devices Market could attain a CAGR of 11.2% during the forecast period (2022-2030), reports Market Research Future (MRFR).

The market for Radiofrequency Ablation Devices was estimated to be worth $ 3.2 billion in 2021, and it is anticipated to increase to $ 11.3 billion by 2027, with a CAGR of 11.9% during forecast period 2022 and 2027.

The market for Radiofrequency Ablation Devices was estimated to be worth $ 3.2 billion in 2021, and it is anticipated to increase to $ 11.3 billion by 2027, with a CAGR of 11.9% during forecast period 2022 and 2027.

The radiofrequency ablation devices market can be divided into three categories based on application: cardiology, cancer, and pain management.

Radiofrequency Ablation Devices Market for Pain Management - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Transparency Market Research (TMR) has published a new report titled, ‘Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global radiof...

Radiofrequency ablation is a minimally invasive medical technique that involves the ablation of selected defective tissues using high frequency alternative current to generate heat.

The radiofrequency ablation devices market is expected to register a CAGR of 11.2% during the forecast period of 2018 to 2023.